|
US4818694A
(en)
|
1982-07-20 |
1989-04-04 |
American Cyanamid Company |
Production of herpes simplex viral protein
|
|
US7264817B1
(en)
|
1983-08-30 |
2007-09-04 |
Genentech, Inc. |
Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
|
|
NZ209308A
(en)
|
1983-08-30 |
1991-08-27 |
Genentech Inc |
Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
|
|
US5244792A
(en)
|
1984-04-06 |
1993-09-14 |
Chiron Corporation |
Expression of recombinant glyoprotein B from herpes simplex virus
|
|
US5171568A
(en)
|
1984-04-06 |
1992-12-15 |
Chiron Corporation |
Recombinant herpes simplex gb-gd vaccine
|
|
US5612041A
(en)
|
1984-07-17 |
1997-03-18 |
Chiron Corporation |
Recombinant herpes simplex gD vaccine
|
|
US5149529A
(en)
|
1988-04-08 |
1992-09-22 |
Board Of Trustees Of Leland Chiron Corporation |
Compositions and treatment for herpes simplex
|
|
EP0471778A1
(en)
|
1989-05-12 |
1992-02-26 |
Ciba Corning Diagnostics Corp. |
Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
|
|
EP0541692B1
(en)
|
1990-08-02 |
1999-05-06 |
Chiron Corporation |
Herpes simplex virus vp16 vaccines
|
|
DK31991D0
(da)
|
1991-02-25 |
1991-02-25 |
Carlbiotech Ltd As |
Peptid og farmaceutisk praeparat indeholdende et saadant peptid
|
|
GB9105992D0
(en)
|
1991-03-21 |
1991-05-08 |
Smithkline Beecham Biolog |
Vaccine
|
|
US5955088A
(en)
|
1992-02-03 |
1999-09-21 |
Cedars-Sinai Medical Center |
Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins
|
|
US5679348A
(en)
|
1992-02-03 |
1997-10-21 |
Cedars-Sinai Medical Center |
Immunotherapy for recurrent HSV infections
|
|
US5593972A
(en)
|
1993-01-26 |
1997-01-14 |
The Wistar Institute |
Genetic immunization
|
|
WO1994029456A2
(en)
|
1993-06-08 |
1994-12-22 |
Abbott Laboratories |
Herpes simplex virus type-2 protease
|
|
JPH09503385A
(ja)
|
1993-08-20 |
1997-04-08 |
スミスクライン・ビーチャム・コーポレイション |
Ｈｓｖ−２ｕｌ２６遺伝子、カプシド蛋白、イムノアッセイおよびプロテアーゼ阻害剤
|
|
GB9325496D0
(en)
|
1993-12-14 |
1994-02-16 |
Smithkline Beecham Biolog |
Vaccines
|
|
US7094767B2
(en)
|
1994-07-22 |
2006-08-22 |
Merck & Co., Inc. |
Polynucleotide herpes virus vaccine
|
|
US5807557A
(en)
|
1994-07-25 |
1998-09-15 |
The Trustees Of The University Of Pennsylvania |
Soluble herpesvirus glycoprotein complex
|
|
US6156319A
(en)
|
1994-07-25 |
2000-12-05 |
The Trustees Of The University Of Pennsylvania |
Soluble herpesvirus glycoprotein complex vaccine
|
|
AUPM873294A0
(en)
|
1994-10-12 |
1994-11-03 |
Csl Limited |
Saponin preparations and use thereof in iscoms
|
|
US5962428A
(en)
|
1995-03-30 |
1999-10-05 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
|
US6197497B1
(en)
|
1995-04-21 |
2001-03-06 |
University Of New Mexico |
Immunoassay for herpes simplex virus
|
|
US5654174A
(en)
|
1995-07-07 |
1997-08-05 |
Competitive Technologies, Inc. |
Herpes simplex virus glycoprotein D variants
|
|
US5876923A
(en)
|
1996-07-26 |
1999-03-02 |
Arch Development Corporation |
Herpes simplex virus ICP4 as an inhibitor of apoptosis
|
|
AU734443C
(en)
|
1996-10-23 |
2005-04-14 |
Wyeth |
Vaccines
|
|
CA2270282A1
(en)
|
1996-11-04 |
1998-05-14 |
Smithkline Beecham Corporation |
Novel coding sequences from herpes simplex virus type-2
|
|
CA2291010A1
(en)
|
1997-06-02 |
1998-12-10 |
Chiron Corporation |
Herpes simplex virus vp22 vaccines and methods of use
|
|
US6015832A
(en)
|
1997-12-31 |
2000-01-18 |
The Regents Of The University Of Michigan |
Methods of inactivating bacteria including bacterial spores
|
|
US6054131A
(en)
|
1998-01-16 |
2000-04-25 |
University Of Maryland Baltimore |
Vaccine composition for herpes simplex virus and method of using
|
|
WO1999045957A2
(en)
|
1998-03-09 |
1999-09-16 |
Smithkline Beecham Biologicals S.A. |
Combined vaccine compositions
|
|
US6248558B1
(en)
|
1998-03-31 |
2001-06-19 |
Vanderbilt University |
Sequence and method for genetic engineering of proteins with cell membrane translocating activity
|
|
DK2272859T3
(en)
|
1998-08-07 |
2015-01-19 |
Univ Washington |
Immunological herpes simplex virus antigens and methods for their use
|
|
US6692752B1
(en)
|
1999-09-08 |
2004-02-17 |
Smithkline Beecham Biologicals S.A. |
Methods of treating human females susceptible to HSV infection
|
|
US6506803B1
(en)
|
1999-04-28 |
2003-01-14 |
Regents Of The University Of Michigan |
Methods of preventing and treating microbial infections
|
|
US6559189B2
(en)
|
1999-04-28 |
2003-05-06 |
Regents Of The University Of Michigan |
Non-toxic antimicrobial compositions and methods of use
|
|
US6635676B2
(en)
|
1999-04-28 |
2003-10-21 |
Regents Of The University Of Michigan |
Non-toxic antimicrobial compositions and methods of use
|
|
KR100768114B1
(ko)
|
1999-06-10 |
2007-10-17 |
메리알 |
애완 동물 및 스포츠용 동물을 위한 ｄｎａ 백신
|
|
GB9921146D0
(en)
|
1999-09-07 |
1999-11-10 |
Smithkline Beecham Biolog |
Novel composition
|
|
HK1044799A1
(zh)
|
1999-09-30 |
2002-11-01 |
University Of Washington |
免疫学上重要的单纯疱疹病毒抗原
|
|
US7196066B1
(en)
|
1999-11-03 |
2007-03-27 |
Powderject Vaccines, Inc. |
DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
|
|
CN1222619C
(zh)
|
1999-12-17 |
2005-10-12 |
惠氏控股公司 |
增强对单纯疱疹病毒疫苗应答的疫苗及其制药应用
|
|
US7078388B2
(en)
|
2000-01-21 |
2006-07-18 |
Merial |
DNA vaccines for farm animals, in particular bovines and porcines
|
|
US7157437B2
(en)
|
2000-03-10 |
2007-01-02 |
Dynavax Technologies Corporation |
Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences
|
|
US6821519B2
(en)
|
2000-06-29 |
2004-11-23 |
Corixa Corporation |
Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
|
|
US20030165819A1
(en)
|
2000-06-29 |
2003-09-04 |
Corixa Corporation |
Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
|
|
ATE349533T1
(de)
|
2000-06-29 |
2007-01-15 |
Corixa Corp |
Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
|
|
US6682892B2
(en)
|
2000-07-13 |
2004-01-27 |
Pharmacia & Upjohn Company |
Method for treating herpes viruses
|
|
JP2004505113A
(ja)
|
2000-07-27 |
2004-02-19 |
ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルベニア |
単純疱疹ウイルス糖蛋白質ｄを用いた組成物及びそれを用いて免疫応答を抑制する方法
|
|
EP1178111A1
(en)
|
2000-08-03 |
2002-02-06 |
Lohmann Animal Health GmbH & Co. KG |
Vaccination against host cell-associated herpesviruses
|
|
US20020094337A1
(en)
|
2000-11-16 |
2002-07-18 |
University Of Maryland, Baltimore |
Prevention of recurrent viral disease
|
|
US6867000B2
(en)
|
2000-12-07 |
2005-03-15 |
Wyeth Holdings Corporation |
Method of enhancing immune responses to herpes
|
|
WO2004030608A2
(en)
|
2001-06-05 |
2004-04-15 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
|
JP4519461B2
(ja)
|
2001-07-31 |
2010-08-04 |
ユニヴァーシティ オブ ワシントン |
免疫学的に重要な単純ヘルペスウイルス抗原およびそれを用いる方法
|
|
AU2002323443A1
(en)
|
2001-09-04 |
2003-03-18 |
Corixa Corporation |
Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
|
|
US20030219448A1
(en)
|
2002-05-24 |
2003-11-27 |
Cedars-Sinai Medical Center |
Peptide epitope-based vaccine for treating herpes simplex virus infections and related diseases
|
|
US20080299140A1
(en)
|
2002-05-24 |
2008-12-04 |
The Regents Of The University Of California, |
Immunogenic Composition and Peptide Sequences for Prevention and Treatment of an Hsv Condition
|
|
DK1523582T3
(da)
|
2002-07-18 |
2009-03-02 |
Univ Washington |
Hurtig, effektiv rensning af HSV-specifikke T-lymfocytter samt HSV-antigener identificeret derved
|
|
US7267940B2
(en)
|
2003-03-04 |
2007-09-11 |
Bio-Rad Laboratories, Inc. |
HSV-2 type-specific immunoassays using glycoprotein G2 peptides
|
|
JP2007505147A
(ja)
|
2003-09-12 |
2007-03-08 |
アンティジェニクス インコーポレーテッド |
単純ヘルペスウイルス感染の治療および予防用ワクチン
|
|
GB0321615D0
(en)
|
2003-09-15 |
2003-10-15 |
Glaxo Group Ltd |
Improvements in vaccination
|
|
JP5492418B2
(ja)
|
2005-11-18 |
2014-05-14 |
ザ オハイオ ステート ユニバーシティー リサーチ ファウンデーション |
ウイルス関連疾患を予防するためのウイルス遺伝子産物およびワクチン接種の方法
|
|
JP2009529576A
(ja)
|
2006-03-10 |
2009-08-20 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
持続感染または潜伏感染を引き起こすウイルスに対するワクチン
|
|
EP2521786B1
(en)
|
2006-07-20 |
2015-06-24 |
Vical Incorporated |
Compositions for vaccinating against hsv-2
|
|
US20090246220A1
(en)
|
2006-08-28 |
2009-10-01 |
Ertl Hildegund C J |
Constructs for enhancing immune responses
|
|
JP5639361B2
(ja)
|
2006-09-08 |
2014-12-10 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
Ｈｓｖ−１及びｈｓｖ−２ワクチン並びにその使用方法
|
|
CA2668100C
(en)
|
2006-11-01 |
2014-12-23 |
Immport Therapeutics, Inc. |
Compositions and methods for immunodominant antigens
|
|
US8057804B2
(en)
|
2006-12-28 |
2011-11-15 |
The Trustees Of The University Of Pennsylvania |
Herpes simplex virus combined subunit vaccines and methods of use thereof
|
|
WO2008085486A1
(en)
|
2006-12-28 |
2008-07-17 |
The Trustees Of The University Of Pennsylvania |
Herpes simplex virus combined subunit vaccines and methods of use thereof
|
|
WO2009006618A2
(en)
|
2007-07-05 |
2009-01-08 |
University Of Kansas |
Herpes simplex virus mutant icp0 protein
|
|
AU2008274887B2
(en)
|
2007-07-06 |
2013-10-31 |
The University Of Sydney |
Epitopes of herpes simplex virus
|
|
SE532551C2
(sv)
|
2008-06-30 |
2010-02-16 |
Senseair Ab |
Ett för spektralanalys anpassat arrangemang
|
|
ES2845203T3
(es)
|
2008-07-01 |
2021-07-26 |
Genocea Biosciences Inc |
Sistema de análisis de antígenos
|
|
EP2379106A4
(en)
|
2008-12-17 |
2012-06-13 |
Genocea Biosciences Inc |
ANTIGENS OF CHLAMYDIAS AND USES THEREOF
|
|
US8460674B2
(en)
|
2009-02-07 |
2013-06-11 |
University Of Washington |
HSV-1 epitopes and methods for using same
|
|
JP2012519724A
(ja)
|
2009-03-09 |
2012-08-30 |
ヘンルイ ウイルリアム |
シグナルペプチドを担体として有する細菌毒素とのハプテン‐担体抱合体及び免疫原性組成物としてのその使用
|
|
EP3756684A1
(en)
*
|
2009-05-22 |
2020-12-30 |
Genocea Biosciences, Inc. |
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
|
|
WO2011106607A2
(en)
|
2010-02-26 |
2011-09-01 |
Juvaris Biotherapeutics, Inc. |
Subunit vaccines for herpes viruses and methods of use
|
|
US20130195961A1
(en)
|
2010-03-09 |
2013-08-01 |
Kejian Yang |
Novel mucosal vaccination approach for herpes simplex virus type-2
|
|
CA2849391A1
(en)
|
2010-10-20 |
2012-04-26 |
Genocea Biosciences, Inc. |
Chlamydia antigens and uses thereof
|
|
EP2643014A4
(en)
|
2010-11-24 |
2015-11-11 |
Genocea Biosciences Inc |
HERPES SIMPLEX TYPE 2 VIRUS VACCINES: COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE
|
|
EP2782597B1
(en)
*
|
2011-11-23 |
2022-04-13 |
Genocea Biosciences, Inc. |
Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
|
|
JP2019537555A
(ja)
|
2016-09-28 |
2019-12-26 |
ジェノセア バイオサイエンシーズ， インコーポレイテッド |
ヘルペスを処置するための方法および組成物
|